Core Laboratories Statistics
Total Valuation
CLB has a market cap or net worth of $755.78 million. The enterprise value is $916.77 million.
| Market Cap | 755.78M |
| Enterprise Value | 916.77M |
Important Dates
The last earnings date was Wednesday, January 29, 2025, after market close.
| Earnings Date | Jan 29, 2025 |
| Ex-Dividend Date | Feb 10, 2025 |
Share Statistics
CLB has 46.83 million shares outstanding. The number of shares has increased by 0.34% in one year.
| Current Share Class | 46.83M |
| Shares Outstanding | 46.83M |
| Shares Change (YoY) | +0.34% |
| Shares Change (QoQ) | -0.10% |
| Owned by Insiders (%) | 1.11% |
| Owned by Institutions (%) | 108.87% |
| Float | 46.30M |
Valuation Ratios
The trailing PE ratio is 24.45 and the forward PE ratio is 17.74. CLB's PEG ratio is 0.99.
| PE Ratio | 24.45 |
| Forward PE | 17.74 |
| PS Ratio | 1.44 |
| Forward PS | 1.41 |
| PB Ratio | 3.00 |
| P/TBV Ratio | 5.17 |
| P/FCF Ratio | 17.43 |
| P/OCF Ratio | 13.40 |
| PEG Ratio | 0.99 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.67, with an EV/FCF ratio of 21.14.
| EV / Earnings | 29.20 |
| EV / Sales | 1.75 |
| EV / EBITDA | 13.67 |
| EV / EBIT | 17.60 |
| EV / FCF | 21.14 |
Financial Position
The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.70.
| Current Ratio | 2.32 |
| Quick Ratio | 1.50 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | 2.06 |
| Debt / FCF | 4.15 |
| Interest Coverage | 4.21 |
Financial Efficiency
Return on equity (ROE) is 13.19% and return on invested capital (ROIC) is 7.37%.
| Return on Equity (ROE) | 13.19% |
| Return on Assets (ROA) | 5.53% |
| Return on Invested Capital (ROIC) | 7.37% |
| Return on Capital Employed (ROCE) | 10.57% |
| Revenue Per Employee | $149,671 |
| Profits Per Employee | $8,971 |
| Employee Count | 3,500 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 6.42 |
Taxes
In the past 12 months, CLB has paid $14.03 million in taxes.
| Income Tax | 14.03M |
| Effective Tax Rate | 30.39% |
Stock Price Statistics
The stock price has increased by +10.40% in the last 52 weeks. The beta is 2.39, so CLB's price volatility has been higher than the market average.
| Beta (5Y) | 2.39 |
| 52-Week Price Change | +10.40% |
| 50-Day Moving Average | 18.12 |
| 200-Day Moving Average | 19.13 |
| Relative Strength Index (RSI) | 38.22 |
| Average Volume (20 Days) | 336,722 |
Short Selling Information
The latest short interest is 6.15 million, so 13.14% of the outstanding shares have been sold short.
| Short Interest | 6.15M |
| Short Previous Month | 6.29M |
| Short % of Shares Out | 13.14% |
| Short % of Float | 13.29% |
| Short Ratio (days to cover) | 20.79 |
Income Statement
In the last 12 months, CLB had revenue of $523.85 million and earned $31.40 million in profits. Earnings per share was $0.66.
| Revenue | 523.85M |
| Gross Profit | 103.33M |
| Operating Income | 52.10M |
| Pretax Income | 39.81M |
| Net Income | 31.40M |
| EBITDA | 67.05M |
| EBIT | 52.10M |
| Earnings Per Share (EPS) | $0.66 |
Balance Sheet
The company has $19.16 million in cash and $180.14 million in debt, giving a net cash position of -$160.99 million or -$3.44 per share.
| Cash & Cash Equivalents | 19.16M |
| Total Debt | 180.14M |
| Net Cash | -160.99M |
| Net Cash Per Share | -$3.44 |
| Equity (Book Value) | 257.74M |
| Book Value Per Share | 5.38 |
| Working Capital | 129.02M |
Cash Flow
In the last 12 months, operating cash flow was $56.39 million and capital expenditures -$13.03 million, giving a free cash flow of $43.36 million.
| Operating Cash Flow | 56.39M |
| Capital Expenditures | -13.03M |
| Free Cash Flow | 43.36M |
| FCF Per Share | $0.93 |
Margins
Gross margin is 19.72%, with operating and profit margins of 9.95% and 5.99%.
| Gross Margin | 19.72% |
| Operating Margin | 9.95% |
| Pretax Margin | 8.82% |
| Profit Margin | 5.99% |
| EBITDA Margin | 12.80% |
| EBIT Margin | 9.95% |
| FCF Margin | 8.28% |
Dividends & Yields
This stock pays an annual dividend of $0.04, which amounts to a dividend yield of 0.25%.
| Dividend Per Share | $0.04 |
| Dividend Yield | 0.25% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.06% |
| Buyback Yield | -0.34% |
| Shareholder Yield | -0.09% |
| Earnings Yield | 4.15% |
| FCF Yield | 5.74% |
Analyst Forecast
The average price target for CLB is $17.25, which is 6.88% higher than the current price. The consensus rating is "Sell".
| Price Target | $17.25 |
| Price Target Difference | 6.88% |
| Analyst Consensus | Sell |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 2.38% |
| EPS Growth Forecast (5Y) | 11.79% |
Stock Splits
The last stock split was on July 9, 2010. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 9, 2010 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CLB has an Altman Z-Score of 3.34 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.34 |
| Piotroski F-Score | 6 |